*The following content is generated by AI and is for reference only.
<h3>Overview</h3>
<p><strong>Brinzolamide</strong> is a topical carbonic anhydrase inhibitor used to lower intraocular pressure. Its core synthesis involves sulfonamide coupling with specific heterocyclic rings. Molecular formula: C<sub>9</sub>H<sub>15</sub>N<sub>3</sub>O<sub>4</sub>S<sub>2</sub>; CAS No.: 128657-20-3.</p>
<h3>Application</h3>
<ul>
<li>Ophthalmology: Adjunctive therapy for glaucoma and ocular hypertension.</li>
<li>Pharmaceutical Manufacturing: API production for ointment formulations.</li>
<li>Research: In vitro studies on enzyme inhibition mechanisms.</li>
</ul>
<h3>Precautions</h3>
<p>Avoid use in patients with severe renal or hepatic impairment. Store in a cool, dry place below 25°C protected from light. Handle with appropriate PPE to prevent inhalation of dust particles.</p>